Metraipolis › archive › dc_47202fafbc12

Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry — Europe PMC PMID:41795103

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41795103
DOI
10.1002/ajh.70268
License (as archived)
solo-consultazione
Archived
2026-10-08T17:15:07.597Z
SHA-256 of the archived text
7c7a5bebd8370e1a1262b815d2de222658e0bfc68a7c656ad91c839b62144245
Stable URL of this page
https://metraipolis.com/documento/dc_47202fafbc12

How to cite

Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry — Europe PMC PMID:41795103 — Europe PMC (en), https://europepmc.org/article/MED/41795103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47202fafbc12 (Metraipolis archive dc_47202fafbc12, sha256 7c7a5bebd8370e1a1262b815d2de222658e0bfc68a7c656ad91c839b62144245)
BibTeX
@misc{dc47202fafbc12,
  title = {Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry — Europe PMC PMID:41795103},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41795103},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47202fafbc12; sha256 7c7a5bebd8370e1a1262b815d2de222658e0bfc68a7c656ad91c839b62144245},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41795103. Agents can read the archived copy with the MCP tool read_document.